BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38248042)

  • 21. The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia.
    Lühmann JL; Stelter M; Wolter M; Kater J; Lentes J; Bergmann AK; Schieck M; Göhring G; Möricke A; Cario G; Žaliová M; Schrappe M; Schlegelberger B; Stanulla M; Steinemann D
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical Genome Mapping in Routine Human Genetic Diagnostics-Its Advantages and Limitations.
    Dremsek P; Schwarz T; Weil B; Malashka A; Laccone F; Neesen J
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Genome Mapping as a Potential Routine Clinical Diagnostic Method.
    Barseghyan H; Eisenreich D; Lindt E; Wendlandt M; Scharf F; Benet-Pages A; Sendelbach K; Neuhann T; Abicht A; Holinski-Feder E; Koehler U
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
    Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
    Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical genome mapping for detection of chromosomal aberrations in prenatal diagnosis.
    Zhang Q; Wang Y; Xu Y; Zhou R; Huang M; Qiao F; Meng L; Liu A; Zhou J; Li L; Ji X; Xu Z; Hu P
    Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1053-1062. PubMed ID: 37366235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating Optical Genome Mapping and Whole Genome Sequencing in Somatic Structural Variant Detection.
    Budurlean L; Tukaramrao DB; Zhang L; Dovat S; Broach J
    J Pers Med; 2024 Mar; 14(3):. PubMed ID: 38541033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical Genome Mapping: A Revolutionary Tool for "Next Generation Cytogenomics Analysis" with a Broad Range of Diagnostic Applications in Human Diseases.
    Garcia-Heras J
    J Assoc Genet Technol; 2021; 47(4):191-200. PubMed ID: 34897113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical genome mapping for prenatal diagnosis: A prospective study.
    Goumy C; Guy Ouedraogo Z; Soler G; Eymard-Pierre E; Laurichesse H; Delabaere A; Gallot D; Bouchet P; Perthus I; Pebrel-Richard C; Gouas L; Salaun G; Salse J; Véronèse L; Tchirkov A
    Clin Chim Acta; 2023 Nov; 551():117594. PubMed ID: 37832906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
    Barford RG; Whittle E; Weir L; Fong FC; Goodman A; Hartley HE; Allinson LM; Tweddle DA
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
    Díaz-González Á; Mora E; Avetisyan G; Furió S; De la Puerta R; Gil JV; Liquori A; Villamón E; García-Hernández C; Santiago M; García-Ruiz C; Llop M; Ferrer-Lores B; Barragán E; García-Palomares S; Mayordomo E; Luna I; Vicente A; Cordón L; Senent L; Álvarez-Larrán A; Cervera J; De la Rubia J; Hernández-Boluda JC; Such E
    Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Application of Optical Genome Mapping (OGM) in Severe Short Stature Caused by Duplication of 15q14q21.3.
    Ke X; Yang H; Pan H; Jiang Y; Li M; Zhang H; Hao N; Zhu H
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
    Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
    Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
    Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
    Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
    Puiggros A; Ramos-Campoy S; Kamaso J; de la Rosa M; Salido M; Melero C; Rodríguez-Rivera M; Bougeon S; Collado R; Gimeno E; García-Serra R; Alonso S; Moro-García MA; García-Malo MD; Calvo X; Arenillas L; Ferrer A; Mantere T; Hoischen A; Schoumans J; Espinet B
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205).
    Paulraj P; Barrie E; Jackson-Cook C
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2307. PubMed ID: 37902189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Optical Genome Mapping in Clinical Genetic Testing of Facioscapulohumeral Muscular Dystrophy.
    Kovanda A; Lovrečić L; Rudolf G; Babic Bozovic I; Jaklič H; Leonardis L; Peterlin B
    Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. nanotatoR: a tool for enhanced annotation of genomic structural variants.
    Bhattacharya S; Barseghyan H; Délot EC; Vilain E
    BMC Genomics; 2021 Jan; 22(1):10. PubMed ID: 33407088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical Genome Mapping for a Patient with a Congenital Disorder and Chromosomal Translocation.
    Ogiwara Y; Hattori A; Ikegawa K; Hasegawa Y; Kuroki Y; Miyado M; Fukami M
    Cytogenet Genome Res; 2022; 162(11-12):617-624. PubMed ID: 37231804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia.
    Suttorp J; Lühmann JL; Behrens YL; Göhring G; Steinemann D; Reinhardt D; Neuhoff NV; Schneider M
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.